The Archive · 2 posts
Explore transformational healthcare solutions with Convatec Group! 🌟 On LSE: CTEC, inspiring advancement in medical innovation. 💡
Convatec maintained its 2026 outlook after resilient first-half growth, while InnovaMatrix impairment and weaker cash flow weighed on reported results.
Showing 1 of 2 posts
Convatec upgrades its medium-term organic growth target to 6-8% following strong 2025 results, margin expansion, and a clear roadmap to mid-20s% margins.
JoshuaFebruary 24, 2026
August 4, 2026